Ohio_Patient_Network

  • Increase font size
  • Default font size
  • Decrease font size
Home

Cannabis Lab Analysis Project

Harborside Health Center, a leader in the medical marijuana dispensary, has taken a huge step forward in bringing modern laboratory technology to the benefit of the medical marijuana patients.  Below is a article from Harborside about the Cannabis lab analysis project.  See FORTUNE magazine article where Harborside Health Center is prominently mentioned.  When medical marijuana becomes a reality here in Ohio, high quality services like Harborside's should be duplicated.  Below is an article from Harborside Health Center.

Harborside Health Center
is pleased to announce it has begun laboratory analysis of its medical cannabis products. This effort has been developed in partnership with the Analytical Laboratory Project, which owns and operates the laboratory facility. All medicinal cannabis products accepted for distribution to Harborside Health Center will be lab tested for safety and potency. For the first time in the 3000-year history of human cannabis consumption, consumers will be provided a scientific assessment of the safety and potency of products prior to ingesting them.

Testing has begun with cannabis flowers and concentrates, and later will include edibles, tinctures, capsules, etc. The testing techniques include gas chromatography/mass spectrometry, gas chromatography/flame ionization detection, and plate culture analysis. Over the course of the past year, the lab has developed its analytical methods in partnership with respected bio-chemists from some of the Bay Area's most prestigious institutions.The testing program has two main components: safety screening and potency quantification. Safety screening analyzes and detects contamination of pathogenic molds, which can threaten the health of patients with compromised immune systems. Potency quantification provides the percentages of three major cannabinoids: THC, CBD, and CBN. Later stages of the program will include the use of patient surveys to develop a comprehensive database of the efficacy of medical cannabis.

Harborside Health Center patients are able to access the testing results in three ways: labels in display cases, labels on products, and a book of complete test results. Labels include percentages for THC, CBD, and CBN; and are posted in medicine display cases, as well as affixed to the products themselves. A book containing complete spectrometry reports for each product is available at the service counter for those patients who desire more detailed analytical results. Testing services commenced with an initial launch period to identify and develop the logistics of sample collection and result identification. After these issues are fully addressed, the testing service will be made widely available to other medical cannabis collectives, and individual patients. These services will include an independent certification component, so patients can be assured that the medicine they are purchasing has been tested.

Last Updated on Tuesday, 29 September 2009 01:37  

Medical Marijuana News

AMA question marijuana’s federal  classification of as a deadly, addictive drug with no medical use.

COLUMBUS, OHIO — At the November American Medical Association conference the AMA reversed it's position on marijuana as a schedule I drug and urges that “marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid based medicines.”  This is a reversal of the AMA position, which has equated marijuana in the same class as heroin.

Marijuana is classified as a Schedule I drug by Ohio and the federal government.  A achedule I drug is defined as a substance with high potential for abuse, no currently accepted medical use in treatment in the United States and a lack of accepted safety standards for its use under medical supervision.  Schedule I drug can not be prescibed by doctors, but the federal government for 40 years has been supply in 300 joints a month to a small group of citiizens.

The AMA now appears to be ready to join other medical organization such as American College of Physicians, American Nurses Association, and others in questioning the federal classification as a deadly addictive drug with no accepted medical use.  Ohio classifies marijuana similarly.

The American College of Physicians, a large organization representing internal medicine doctors, made a similar statement as the AMA. The ACP "supports programs and funding for rigorous scientific evaluation of the potential therapeutic benefits of medical marijuana and the publication of such findings”.

"The American Nurses Association (ANA) recognizes that patients should have safe access to therapeutic marijuana/cannabis. Cannabis or marijuana has been used medicinally for centuries. It has been shown to be effective in treating a wide range of symptoms and conditions." {Providing Patients Safe Access to Therapeutic Marijuana/Cannabis," American Nurses Association (ANA) website, Mar. 19, 2004}

Ohio and the federal government is going to find it increasingly difficult to support their claims that cannabis (aka marijuana) as having no medical value.  A majority of Ohio citizens supports medical marijuana as evidenced by the University of Cincinnati's Institute for Policy Research recent poll results.

Ohio Patients are working to change Ohio laws concerning medical marijuana.